These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9681948)

  • 21. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pertussis toxin lesions of the rat substantia nigra block the inhibitory effects of the gamma-hydroxybutyrate agent, S(-)HA-966 without affecting the basal firing properties of dopamine neurons.
    Shepard PD; Connelly ST
    Neuropsychopharmacology; 1999 Nov; 21(5):650-61. PubMed ID: 10516961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of nigral dopamine neurons by systemic and local apomorphine: possible contribution of dendritic autoreceptors.
    Akaoka H; Charléty P; Saunier CF; Buda M; Chouvet G
    Neuroscience; 1992 Aug; 49(4):879-91. PubMed ID: 1359456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zinc increases the excitability of dopaminergic neurons in rat substantia nigra.
    Chung J; Chang S; Kim Y; Shin H
    Neurosci Lett; 2000 Jun; 286(3):183-6. PubMed ID: 10832015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological properties of nigrothalamic neurons after 6-hydroxydopamine lesions in the rat.
    MacLeod NK; Ryman A; Arbuthnott GW
    Neuroscience; 1990; 38(2):447-56. PubMed ID: 2124665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysis.
    Tepper JM; Creese I; Schwartz DH
    Brain Res; 1991 Sep; 559(2):283-92. PubMed ID: 1794102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
    Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
    Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Firing properties of substantia nigra dopaminergic neurons in freely moving rats.
    Freeman AS; Meltzer LT; Bunney BS
    Life Sci; 1985 May; 36(20):1983-94. PubMed ID: 3990520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G alpha q/11 mediates cholecystokinin activation of the cationic conductance in rat substantia nigra dopaminergic neurons.
    Wu T; Wang HL
    J Neurochem; 1996 Mar; 66(3):1060-6. PubMed ID: 8769867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GABA(A) and GABA(B) antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo.
    Paladini CA; Tepper JM
    Synapse; 1999 Jun; 32(3):165-76. PubMed ID: 10340627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence.
    Grace AA; Bunney BS
    Science; 1980 Nov; 210(4470):654-6. PubMed ID: 7433992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
    Olds ME
    Neuroscience; 1988 Feb; 24(2):465-76. PubMed ID: 3362349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible intermixing of neurons from the subthalamic nucleus and substantia nigra pars compacta in the guinea-pig.
    Overton PG; O'Callaghan JF; Greenfield SA
    Exp Brain Res; 1995; 107(2):151-65. PubMed ID: 8773236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topographic heterogeneity of substantia nigra neurons: diversity in intrinsic membrane properties and synaptic inputs.
    Hajós M; Greenfield SA
    Neuroscience; 1993 Aug; 55(4):919-34. PubMed ID: 7901802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.